Efficacy and safety of peficitinib in rheumatoid arthritis
Sign Up to like & getrecommendations! Published in 2020 at "Modern Rheumatology"
DOI: 10.1080/14397595.2020.1794103
Abstract: Abstract Peficitinib is a Janus kinase (JAK) inhibitor, newly developed and approved in Japan. In contrast to other JAK inhibitors, it is a unique pan-JAK inhibitor, demonstrating inhibition of all JAKs. In patients with rheumatoid… read more here.
Keywords: jak; efficacy safety; safety peficitinib; rheumatoid arthritis ... See more keywords